Cargando…
The therapeutic relevance of a BRCA2 mutation in a patient with recurrent thymoma: a case report
BACKGROUND: Thymomas are characterized by a low tumor mutation burden and a paucity of actionable mutations. Clinical behavior can vary from relatively indolent to very aggressive and impact survival. Platinum-based chemotherapy is the primary treatment modality for inoperable disease and is palliat...
Autores principales: | Sigurdson, Samantha, Marom, Edith M., Rimner, Andreas, Shepherd, Annemarie, Szolkowska, Malgorzata, Roden, Anja C., Marino, Mirella, Tomiyama, Noriyuki, Ball, David, Falkson, Conrad, Rajan, Arun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792822/ https://www.ncbi.nlm.nih.gov/pubmed/36582974 http://dx.doi.org/10.21037/med-22-9 |
Ejemplares similares
-
Case presentations and recommendations from the 2018 ITMIG Annual Meeting
por: Sigurdson, Samantha, et al.
Publicado: (2020) -
Case presentation and recommendations from the April 2019 ITMIG tumor board: an international multidisciplinary team
por: Sigurdson, Samantha, et al.
Publicado: (2019) -
Case presentation and recommendations from the April 2018 ITMIG tumor board: an international multidisciplinary team
por: Sigurdson, Samantha S., et al.
Publicado: (2019) -
Thymomas in children
por: Szolkowska, Malgorzata
Publicado: (2019) -
ITMIG 2021 Tumor Board: a case of a 37-year-old man with TNM stage IVA thymoma
por: Zielinski, Marcin, et al.
Publicado: (2022)